Michael A. Metzger, Director at CTI BIOPHARMA CORP (CTIC), sold 178,500 shares at $5.53 ($997K) on 2022-11-08, disclosed to the SEC on 2022-11-10.
Open-market sale of $997k CTIC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.53 | 50,058 | $277K | 27.8% |
| 2 | $5.53 | 50,058 | $277K | 27.8% |
| 3 | $5.65 | 36,942 | $209K | 20.9% |
| 4 | $5.65 | 36,942 | $209K | 20.9% |
| 5 | $5.70 | 4,500 | $26K | 2.6% |
| Total | $5.58 avg | 178,500 |
| $997K |
| 100% |
| Filing → |
| SNDX | SELL | 2026-02-10 | $361K | — | Filing → |
| SNDX | SELL | 2026-02-06 | $153K | — | Filing → |
| SNDX | SELL | 2025-09-08 | $5.2M | — | Filing → |